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ABSTRACT
Objective: To estimate the prevalence of missed opportunities for vaccination (MOV) among 
children aged 0 – 23 months attending healthcare facilities in Africa and explore the factors 
responsible for MOV using systems thinking.
Research design and methods:  We conducted a systematic review and meta-analysis of 
studies reporting the proportion MOVs. Five electronic databases were searched. A random 
effects model was fitted to obtain pooled estimates of MOV and a causal loop diagram (CLD) 
was constructed to explore the dynamics of the causes of MOV. MOV was defined as any 
contact with health services in Africa, by an unvaccinated or under-vaccinated child, aged 0 – 
23 months, who is eligible for vaccination and free of any contraindication, which does not result 
in vaccination.
Results: 421 publications were found, of which 20 studies from 14 countries were included. The 
pooled prevalence of MOV was estimated to be 27.26% (95%CI: 18.80 – 36.62). A CLD with 
seven reinforcing and two balancing loops were constructed.
Conclusion: Our findings suggest that about one in every four children under the age of two 
who visited health facilities in 14 African countries missed the vaccination they were eligible to 
receive. To enable continent-wide estimates, more MOV assessments are required. 
Keywords: immunization, missed opportunities for vaccination, children, Africa, vaccines, 
systematic review, causal loop diagram, systems thinking
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1.0 INTRODUCTION
According to the World Health Organization (WHO), a missed opportunity for vaccination (MOV) 
is defined as “any contact with health services by an individual (child or person of any age) who 
is eligible for vaccination (e.g. unvaccinated or partially vaccinated and free of contraindications 
to vaccination) which does not result in the person receiving one or more of the vaccines doses 
for which he or she is eligible” (1). It can occur during clinic visits for preventive care such as 
immunization and growth monitoring or curative care for injuries and ailments (2). Nevertheless, 
higher prevalence have been reported in curative care settings (2). In a previous study, the 
median MOV prevalence in preventive health services was 32%, as compared to 42% in 
curative health services (2). MOV has been identified as an important contributor to poor 
childhood immunization coverage level (2, 3). According to the World Health Organization 
(WHO), MOV accounts for a fraction of children who do not receive DTP3 (third dose of 
diphtheria-tetanus-pertussis containing vaccines) in Mozambique, Uganda and Republic of the 
Niger (1). 
The reasons for MOV are multi-faceted, involving multiple stakeholders such as caregivers, 
health workers and health system managers (4-8). In a health facility survey conducted in 
Kenya, vaccine stockout, BCG syringe stockout, child illness and underweight were reported as 
reasons for not vaccinating children during clinic visits (4). Researchers in Eswatini (formerly 
Swaziland) reported that MOV occurred more frequently among children requiring first dose of 
all vaccines antigens because they usually do not possess vaccination cards (5). Surprisingly, 
they also found that MOV was higher in healthcare facilities that offer integrated services (5). 
With approximately 10 million children in Africa’s annual birth cohort remaining unvaccinated or 
partially vaccinated, the need to position MOV reduction as a cross-cutting health systems 
strengthening priority has become pertinent at district and national level (9, 10). Encouragingly, 
the World Health Organization has updated its strategy on MOV to focus on children aged 0 – 
23 months in health service settings (11). In addition, tools and protocols for assessments have 
been simplified and standardized for ease of use and applicability across diverse settings (11). 
However, existing literature on synthesized evidence of the prevalence of MOV, which is 
necessary for informed decision making on the continent, has limitations. 
Systematic reviews of health facility-based MOV assessment in Africa where majority of 
unimmunized children live are scarce (12).  Previous reviews on MOV have, hitherto, combined 
estimates from population-based and health facility-based surveys  (2, 3).  Also, the age 
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category of participants in individual studies that were considered in earlier reviews vary widely 
from newborns to adolescents whereas the current focus is on children less than two years of 
age (2, 3). 
Furthermore, previous reviews have described the factors responsible for MOV using linear 
approaches (2, 3). Such approaches assume that factors interact with an outcome linearly to 
produce expected output (13). Under real world condition, the immunization sub-system can be 
described as a complex system both in design and number of stakeholders which can include 
caregivers, health workers, health facility managers and policy makers among others (13, 14). 
All these components interact in a nonlinear and dynamic manner to produce unexpected output 
(13). In addition, contextual factors such as resource availability and sociocultural beliefs that 
are at play where these systems are located constantly influence the behavior of stakeholders 
(15, 16). Growing literature on complexity offers new insights on how to contextualize problems 
from a system-wide perspective (17-19). 
Against this background, we aimed to estimate the prevalence of missed opportunities for 
vaccination among children aged 0 – 23 months attending healthcare facilities in Africa, and 
explore the dynamics of factors responsible for it using systems thinking. This will provide 
relevant evidence for health policy makers and practitioners on the continent.  
1.1 Theoretical underpinning of systems thinking approach  
Several studies have proposed useful conceptual frameworks for exploring factors that are 
associated with non-vaccination or partial-vaccination among children (20-22). These studies 
have highlighted the multi-faceted nature of the determinants of suboptimal vaccination (20-22). 
In fact, one of the frameworks enumerated health worker-, health system-, and caregiver-related 
problems that can predict MOV (20). Using complex adaptive system (CAS) theory lens in this 
current study, we advanced existing conceptual frameworks by elucidating how these multiple 
factors that are associated with MOV potentially interact with each other (23). CAS theory offers 
a way of making sense of phenomenon that are dependent upon the behavior of various 
stakeholders and their responses (24). The advantage of viewing a problem through this lens is 
that it accounts for the variation in the degree of influence of stakeholders and the 
unpredictability of their behaviors (25). In addition, it recognizes the dynamical interactions and 
synergies that occur continuously among multiple factors (25). Applying this theory provides 
further insights into leverage points within the systems that can guide the prioritization of 
innovative solutions. To conceptualize the dynamic architecture of the factors that cause MOV 
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among children within an Africa context, causal loop diagram (CLD) was employed (26). This 
was to enabled an explicit visual illustration of the relationship between these variables (26). 
Some of the key elements of causal loop diagrams include causality, delays, polarity, and 
feedback loop which can either be reinforcing or balancing (27). 
2.0 METHODS
2.1 Protocol and registration
A protocol that pre-specified the objectives and methodology including eligibility criteria was 
developed in advance and registered on PROSPERO with ID number: CRD42018098736 
(https://www.crd.york.ac.uk/PROSPERO/). This systematic review was reported according to 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline (28).
2.2 Eligibility criteria
We included surveys conducted in health facilities regardless of location characteristics (rural or 
urban) that reported the proportion of children aged 0 – 23 months who remained unvaccinated 
or under-vaccinated despite contact with health services in Africa. The eligibility criteria is 
summarized on Table 1. 
2.3 Information sources
2.3.1 Electronic database
To identify relevant publications, a comprehensive and systematic search of electronic 
databases was performed. A total of five electronic databases were searched on the internet 
and they include MEDLINE (via Pubmed), Scopus, Google Scholar, African Index Medicus, and 
WHO Institutional Repository for Information Sharing (IRIS). No date, document format or 
language restriction was specified. Search terms comprising of free text and medical subject 
headings (MeSH) were used in querying all the electronic databases. The search terms 
included: “immunization”, “vaccination”, “missed opportunities”, “children”, “childhood”, 
“prevalence”, “burden”, “epidemiology”, “Africa”, and “sub-Saharan Africa”. A detailed search 
strategy was developed for Pubmed and adapted for the other databases. See Appendix 1 for 
detailed search strategy. The last database search was conducted on 21st November 2018. 
Since Google yields high search volume, we limited search to the first 250 results (29). 
2.3.2 Other sources
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Focal persons from WHO and MOV partner organizations including United Nations Children’s 
Fund (UNICEF), United States Centers for Disease Control and Prevention (CDC), Medicins 
Sans Frontieres (MSF), John Snow Inc (JSI), Agency de Medecine Preventive (AMP), Village 
Reach, Clinton Health Access Initiative (CHAI), Gavi – the vaccine alliance, and Bill and Melinda 
Gates Foundation (BMGF) were contacted for any unpublished manuscripts or grey literature on 
MOV assessments in Africa. Finally, we searched the reference list of relevant articles to 
identify publications that were not indexed on the databases. 
2.4 Study selection 
Three authors (AAA, ABW and AMS) screened the titles and abstracts of all the publications 
obtained from databases for relevance.  Then, they independently assessed the full text of 
relevant studies against the eligibility criteria. During this process, disagreements were resolved 
through discussion.  Reviewers were not blinded to author or journal name. 
2.5 Data collection process
A data extraction sheet was developed using Microsoft Excel 2016. The tool was pilot-tested 
with five randomly selected studies which informed some minor refinement. Data extraction was 
performed by two authors (ABW and AMS) and disagreement were resolved by discussion.
2.6 Data items
The data that were extracted from each included study are as follows: Study title, year of 
publication, surname of first author, affiliated institution(s) of first author, country of assessment,  
level of healthcare (primary/secondary/tertiary), sample size of children aged 0 – 23 months, 
number of children who missed vaccines or vaccines doses among children aged 0 – 23 months 
during facility visit, proportion of MOV, sampling strategy,  location characteristics of health 
facilities, means of assessing vaccination status, number of health facilities, and factors 
associated with MOV. Additional information about geographical region (using United Nations 
“standard country or area codes for statistical use”) and WHO regions; Regional Office for Africa 
(AFRO) and Regional Office for the Eastern Mediterranean (EMRO) were added. 
2.7 Risk of bias in individual studies
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The Risk of Bias Assessment tool for Non-randomized Studies (RoBANS) and ACROBAT-NRSI 
(“A Cochrane Risk Of Bias Assessment Tool for Non-Randomized Studies”) (see Box 1) was 
adapted and used in this review (30, 31). The risk of bias was assessed by scoring (low risk = 1, 
unclear = 0, high risk = -1) each bias type for each publication and the total score was used as 
the summary assessment of risk of bias. 
2.7 Summary measure
The summary measure that was computed is proportion of missed opportunities for vaccination. 
This was defined as the number of children aged 0 – 23 months who remained unvaccinated or 
under-vaccinated despite contact with health services divided by total number of children aged 0 
– 23 months attending health facility. 
3.0 DATA ANALYSIS
3.1 To estimate the prevalence of missed opportunities for vaccination among 
children aged 0 – 23 months attending healthcare facilities in Africa.  
To compute the summary effected size, first, proportions that were extracted from individual 
studies were transformed using the Freeman-Tukey double arcsine transformation method (32). 
This was to avoid skewness as the proportion of MOV was reported to be zero in one of the 
study (33).  The transformation serves to stabilize the variance thus enabling transformed 
proportions to approximate normal distribution (32). Then, the normalized proportions and their 
asymptotic variances were used to compute the pooled estimate. Dersimonian and Laird 
random effect model was fitted using number of children who missed vaccination (r) and total 
sample size of children (n) to obtained the pooled prevalence of MOV for each geographical 
region and Africa (34). In the model, study specific confidence limit for the pooled estimate was 
constructed using Clopper-Pearson method (exact method) (35). Stata ‘metaprop’ package was 
used to perform this meta-analysis (36). Heterogeneity across studies was calculated and I2 was 
obtained (37).  To explore the heterogeneity, potential effect modifiers were considered in 
univariable meta-regression analysis. These include study characteristics such as year of 
publication, geographical region, WHO region, sampling strategy, sample size, number of health 
facilities, location characteristics, and means of assessing vaccination status. To check for bias, 
a funnel plot was constructed (38). Then Egger’s test was performed with included studies to 
explore for publication bias (39). In addition, a contour-enhanced funnel plot was constructed 
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(40). Meta-analysis results were reported as pooled prevalence with 95% confidence intervals 
(CIs), while meta-regression results are reported as odds ratio with 95% CIs. All analyses were 
performed in Stata 14.2. 
3.2 To identify factors associated with missed opportunities for vaccination among 
children aged 0 – 23 months attending healthcare facilities in Africa. 
Factors were extracted from the included studies and then categorized into three themes as 
follows: health service related factors, caregiver/parents related factors, and health workers 
related factors. The authors brainstormed on the identified factors before using them to build a 
causal loop diagram (CLD). AAA constructed the CLD. While CSW, OAU, MAG, ABW, ASM 
and AAA validated the diagram. The validation was done by manually assessing the structure of 
the diagram and proposed linkages (41). The linkages were assessed for clarity and plausibility. 
Disagreements were resolved through discussions. 
3.3 To describe the dynamics of identified factors and their relationship with missed 
opportunities for vaccination.  
Variables were linked using arrows (             ) to denote the direction of influence. If the 
influence is in the same direction, a positive (+) polarity is used, otherwise, a negative (-) 
polarity is indicated. In the diagram, we termed closed cycles as balancing feedback loop 
(denoted with B) if the effect of a change in the variables results in a counter change in the 
opposite direction, and reinforcing feedback loop (denoted with R) if the effect of a change in the 
variables within the loop will propagate more change in the same direction. CLD was built with 
Vensim PLE x32 (42). 
4.0 RESULTS
4.1 Characteristics of included study
A total of 421 publications; 102 from Pubmed, 69 from Scopus, and 250 from Google Scholar 
were retrieved. Upon removing duplicates, 366 studies were left. An additional 312 studies that 
were not relevant to our study were removed. A total of 54 full text articles were selected for 
critical reading. Finally, 20 studies (three in French language) conducted across different level of 
healthcare were included in this review (4, 5, 7, 33, 43-58). The study selection process for this 
systematic review is presented on the PRISMA flow chart in Figure 1. No unpublished 
manuscript or reports were received. To avoid double counting, a thesis was excluded since it 
had also been published as a manuscript (51). The included studies involved 6030 children 
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under two years of age from 14 countries and were published between 1989 and 2017 as 
shown in Figure 2. 
The countries are distributed across both WHO regions (EMR, 5; AFR, 15) on the continent. 
Sudan and Egypt are countries on the African continent that are in the EMR. The number of 
MOV assessments were highest in Sudan and Nigeria. Other characteristics of included studies 
are on Table 2.  
4.2 Risk of bias of included studies
Based on sample selection, 4 out of 20 studies were assessed as having low risk, and risk was 
unclear in 8 studies thus yielding a score of -4. Participation rate was classified low risk in 17 
studies and unclear in 3, hence, a score of 17. Analysis was appropriate for type of sample 
across studies, thus yielding a score of 20. Detailed assessment of risk of bias for each of the 
included studies is shown in Box 2.  
4.3 Prevalence of missed opportunities for vaccination in Africa
The prevalence of missed opportunities for vaccination ranged from 0% (95%CI: 0.00 – 4.74) in 
Zimbabwe to 64.07% (95%CI: 58.04 – 69.80) in Sudan. Prevalence of MOV by geographical 
region are as follows: Western Africa [20.02% (95%CI: 15.87 – 24.53)], Eastern Africa [18.92% 
(95%CI: 4.43 – 40.16)], Southern Africa [39.38% (95%CI: 34.45 – 44.41)] and Northern Africa 
[46.99% (95%CI: 32.82 – 16.41)]. The overall random pooled prevalence on MOV among 
children aged 0 – 23 months in African health facility-based surveys is 27.26% (95%CI: 18.80 – 
36.62). The variation in effect size that is attributable to heterogeneity (I2) is 98.36%. Figure 3 is 
a forest plot of the prevalence of MOV for 20 studies conducted in Africa.
Following univariable meta-regression analysis of study characteristics, it was found that the 
WHO region where the study was conducted had an unadjusted odds ratio (OR) of 3.12 
(95%CI: 1.10 – 8.83) with p-value of 0.03. The unadjusted OR and p-value for other study 
characteristics are presented on Table 3. 
The funnel plot for estimates obtained in this study appeared asymmetrical. Following Egger’s 
test, the estimated bias coefficient was -9.66 (95%CI: -16.87 - -2.45) with standard error of 3.42 
and p-value of 0.012 thus providing evidence of small study effects. In the contour enhance 
funnel plot shown in Figure 4, studies appear to be missing in area of low statistical significance 
thus suggesting presence of publication bias. 
4.4 Dynamics of missed opportunities for vaccination
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Of the 20 studies included in this review, 18 reported factors responsible for missed 
opportunities for vaccination. Using data extracted from individual studies, a causal loop 
diagram of these factors was constructed. We found seven reinforcing loops and two balancing 
loops. The first reinforcing loop (R1) depicts the direct relationship between health services and 
missed opportunities, while the second reinforcing loop (R2) shows the interplay between 
availability of commodities in health facilities and missed opportunities. Other loops are shown 
below in Figure 5. 
5.0 DISCUSSION
5.1 Main findings
This study advances current knowledge on missed opportunities for vaccination in Africa. The 
overall pooled prevalence of MOV was found to be 27.26% (95%CI: 18.80 – 36.62). To the best 
of our knowledge, this is the first systematic review to compute the prevalence of MOV among 
children aged 0 – 23 months on the continent. In addition, this review focused on health facility-
based surveys. The study also explored regional difference in MOV prevalence. Furthermore, 
elements of complexity was innovatively used within the framework of a systematic review to 
explore the dynamics of missed opportunities for vaccination in Africa. Causal loop diagram was 
used to illustrate the interrelationships between variables including feedbacks and delays. In our 
diagram, seven reinforcing loops and two balancing loops were identified. 
5.2 Limitations and strengths of the study
Our findings should be interpreted bearing in mind the limitations and strengths of this study. 
The included studies span over two decades, from 1989 to 2017, which we consider to be a 
limitation. There would have been several changes to national immunization policies between 
those years. Although we would have conducted a subgroup analysis to stratify by time period, 
only 20 studies were found. Due to this paucity of data, we had to be cautious so as not to 
produce estimates that might be misleading. In this study, we use a comprehensive and 
systematic search strategy, but we cannot conclude that all relevant publications were retrieved. 
Only 20 studies covering 14 out of the 54 countries in Africa were found. Even though 
subregions within the continent were represented, the findings should still be interpreted with 
caution. Also, we observed high heterogeneity (I2 of 98.36%) that was in part explained by the 
variation in WHO regions (Africa and Eastern Mediterranean). As a systematic review of 
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observational studies that included surveys from multiple countries, heterogeneity is to be 
expected. It is likely that some factors or links might be missing in the CLD. This is especially 
important as we relied on published literature as our source of information. Also, as a 
conceptual tool, the direction of causality and polarity are mostly based on the experiences of 
the authors. As a result, authors from different contexts might not necessarily replicate the same 
diagram. A key strength of this study is that it was conducted in accordance with a standardized 
systematic review guideline. Our search included both published and unpublished literature. 
Also, five electronic databases were searched with no date or language restrictions. We 
predefined our eligibility criteria and three reviewers used it to rigorously assess included 
studies. In addition, we transformed the proportions that were extracted from individual studies 
to avoid skewing our estimates. Another key strength of this study is that we used complex 
adaptive systems lens to enhance the description of the factors that are associated with MOV. 
This guided our interpretation of how the variables interrelate thus accounting for underlying 
complexity. Primary studies that ar  included in systematic reviews are a good source of data 
on moderators. Using causal loop diagrams to explicitly describe these factors within the context 
of a systematic review is a novel approach, which further broadens the applications of systems 
thinking. 
5.3 MOV in Africa
African states, alongside other WHO-member countries in 2012, endorsed the Global Vaccine 
Action Plan (GVAP) which aims to achieve 90% national immunization coverage and 80% 
immunization coverage at district level, among other targets, by 2020 (59). To support 
implementation efforts within the African region, a Regional Strategic Plan for Immunization 
2014 – 2020 was developed (60). Furthermore, in 2016, African countries reiterated their 
commitment to universal access to immunization within the framework of the sustainable 
development goals (SDG). However, the performance of immunization systems on the continent 
remained suboptimal (61). So far, only 18 countries have met the GVAP target of 90% national 
immunization target (9). According to the 2017 assessment report of GVAP, immunization 
coverage in the African region, at 74%, was lowest in the world (61). 
Although several activities to improve immunization coverage are being implemented in various 
countries across the continent, health facility-based efforts receive less attention. Therefore, 
children who are eligible for vaccination often make contact with health services and exit without 
receiving the vaccine(s) or vaccine dose(s) for which they are due, thus resulting in missed 
opportunities for vaccination. Our study confirmed this, as we found that about 1 in 4 children 
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aged 0 – 23 months in 14 African countries were missed for vaccination in healthcare settings. 
The estimate we obtained in our study is lesser than MOV estimates for low- and middle-income 
countries [32.2% 95%CI (26.8 – 37.7)] most likely because we limited our age group to only 
children less than two years as recommended in the updated MOV methodology (1, 3). 
Home-based records (HBR) play an important role in MOV assessments (1). It enables accurate 
quantification of the number of children who missed vaccination, as opposed to caregiver recall. 
Accordingly, in the updated MOV assessment methodology, immunization history that is 
obtained from HBR or any temporary immunization document is recommended (1). In this 
review, we found that majority of the studies assessed vaccination status using a combination of 
HBR and recall. To further improve the accuracy of assessments, there is a need to adhere to 
the updated MOV methodology. 
This study presented a conceptual diagram that proposed the direction of relationship for 
several caregiver, health worker and health systems factors that cause MOV. Loop R1 indicates 
that an increase in health service delivery will decrease missed opportunities for vaccination, 
and in turn, an increase in the number of children being immunized upon contact with health 
services will impact on health services as this can constraint resources. In loop R2 we postulate 
that an increase in health services delivery will increase the utilization of vaccines and syringes 
in clinics, and thus lead to stock-out of these consumables thereby increasing missed 
opportunities for vaccination. Loop R3 shows that increased literacy level among caregivers is 
likely to increase knowledge of expanded programme on immunization (EPI) which can in turn 
improve caregiver possession of vaccination cards to enable routine screening during clinic or 
hospital visits. 
Reluctance to open new vials of vaccines stemming from poor attitude and practices among 
health workers can increase missed opportunities for vaccination as shown in loop R4. In 
addition, information about MOV in a clinic can improve health workers attitude and practice 
toward immunization. Targeted training and capacity building in clinics and hospitals can reduce 
the level at which health workers fail to vaccinate as a result of false contraindication, which can 
then reduce missed opportunities for vaccination as shown in loop R5. An increase in health 
service delivery can result in missed opportunities for vaccination through clinic delays and 
increase in time spent by caregivers in clinic as shown in loop R6. Loop R7 show that poor 
attitude and practice of health workers towards immunization can decrease the level of attention 
given to vaccination history among children, which will further decrease the frequency of routine 
vaccination card screening in clinics thereby worsening missed opportunities for vaccination.
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Loop B1 indicates that increased health service delivery will result in better confidence in the 
system thus increasing caregiver utilization and subsequently reducing missed opportunities for 
vaccination.  Training and capacity building programmes can improve the attitude and practice 
of health workers involved in immunization services, and this can reduce non-vaccination due to 
false contraindication in loop B2. Some leverage points for interventions include routine 
screening of vaccination cards (R7), addressing false contraindication to vaccinate (R5), 
preventing reluctance to open new vial (R4), preventing consumable stock-out (R2) and 
reducing clinic delay (R6) among others were identified. 
Several factors that can influence caregiver utilization of immunization services were depicted. 
Those that improve utilization include literacy level of caregivers, low parity and previous 
immunization in the child. While factors such as illness in the child, older child, fever or illness 
following last immunization, cost (transportation to health facility or service charges), when a 
caregiver was previously denied immunization, first immunization, language barrier with health 
workers, forgot about child’s immunization, fear of adverse effects, when the caregiver is ill, low 
socioeconomic status, fear of vaccinating an ill child, distance to health facilities, having an 
underweight child, and traditional beliefs and customs can all reduce utilization. Also, the 
dynamics of factors that affect level of health service delivery were shown. Those that can 
increase level of health service delivery include integration of services, emphasizing preventive 
care in clinics, provision of preventive services. Whil  those that can reduce service delivery 
include curative services, workload, manpower and vaccination clinic scheduling. 
This research has implications for policy and practice. The study provided additional evidence 
regarding the magnitude of MOV among children aged 0 – 23 months in Africa. However, only 
20 studies met the inclusion criteria. Considering the diverse setti gs on the continent, more 
context-specific surveys that focuses on this age group is required. The occurrence of MOV in 
health services setting within Africa is unacceptable given the low immunization coverage in the 
general population. Decision makers at regional and national level need to emphasize tailored 
strategies to address MOV in broader health sector plans so as to maximize the use of existing 
health facilities for the provision of immunization services. 
The causal loop diagram illustrated the dynamics of factors responsible for missed opportunities 
for vaccination. The diagram shows potential leverage points that can be useful for designing 
facility-based interventions including quality improvement interventions. Given that multiple 
stakeholders were identified, innovative, facility-generated solutions that targets them 
concurrently might be useful. 
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Our research recommendations are presented in Box 3 using the evidence, population, 
intervention, comparison, outcome, time stamp EPICOT+ format (62). 
6.0 CONCLUSION
In conclusion, this study provided an estimate of the prevalence of MOV among children aged 0 
– 23 months based on primary studies from 14 African countries. The findings suggest that 
about one in every four children under the age of two who visit health facilities miss the 
opportunity to receive immunization services in these countries. This indicates that efforts to 
address MOV within health service settings in these countries can considerably improve 
immunization coverage. To enable continent-wide estimates, more MOV assessments are 
required. In addition, the interrelationships depicted in the CLD enhanced the understanding of 
factors and revealed leverage points for interventions.
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Table 1: Pre-specified eligibility criteria for including and excluding observational studies 
on burden of missed opportunities for vaccination in Africa
Characteristics Inclusion Criteria Exclusion Criteria
Population
Children aged 0 - 23 months 
of age
Other populations such as 
adolescents 
Outcome
Missed opportunities for 
vaccination: by vaccine and 
vaccine dose. 
Missed opportunities for 
prophylactic antibiotics
Missed opportunities for 
vaccination (MOV) is defined 
as "any contact with health 
services in Africa by an 
unvaccinated or under-
vaccinated child aged 0 – 23 
months who is eligible for 
vaccination and free of any 
contraindication which does 
not result in vaccination"
Study type
Facility based surveys 
regardless of study design. Population based surveys
Context
Health care facilities (primary, 
secondary or tertiary) within 
Africa 
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Box 1: Risk of bias assessment
Bias type Low-risk of bias High-risk of bias Unclear risk of 
bias
Selection (sample 
population)
participants selected 
randomly
Sample selection 
ambiguous and sample 
unlikely to be 
representative
Insufficient 
information
Selection 
(participation rate)
High participation rate 
(>70-85%)
Low participation rate 
(<70%)
Insufficient 
information
Performance bias 
(outcome 
assessment)
Objective measures of 
MOV (i.e. health records / 
cards)
Self-reported measure 
of MOV 
Insufficient 
information
Performance bias 
(analytical methods 
to control for bias)
Analysis appropriate for 
type of sample 
(unadjusted, univariable 
analyses etc.)
Analysis does not 
account for common 
adjustment (adjusted, 
multivariable analyses)
Insufficient 
information
Other form of bias There is no evidence of 
bias from other sources.
There is potential bias 
present from other 
sources
Insufficient 
information
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Figure 1: PRISMA Flow chart 
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Figure 2: A line graph of published studies on MOV in Africa
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Table 2: Characteristics of studies that assessed the prevalence of missed opportunities 
for vaccination among children aged 0 – 23 months in health facilities in Africa
S/No
Study 
ID
First 
Author Country
Geographic 
Region 
(United 
Nations 
classification)
Definition of 
MOV
Number 
of 
health 
facilities
Year of 
MOV 
Assessment
Location 
Characteristics
Level of 
healthcare
Means of 
assessing 
vaccination 
status 
1 MOV001
Borus 
(2004) Kenya Eastern Africa
"Missed 
immunisation 
opportunities 
were assessed 
as a proportion of 
age-eligible 
children who 
were attended to 
at surveyed 
health facillities 
for various 
reasons" 6 2001 Urban Mixed
Combined 
vaccination 
cards and 
self 
reporting
2 MOV002
Brugha 
(1995) Ghana Western Africa
"Failure to 
receive all the 
immunizations 
for which they 
were eligible on 
at least one visit 
to an under-fives 
clinic" 3 Not clear Rural Secondary
Combined 
vaccination 
cards and 
self 
reporting
3 MOV003
Daly 
(2003)
Eswatini 
(Previously 
Switzerland)
Southern 
Africa
"Any child who 
was not up to 
date, lacked 
appropriate 
contraindications, 
or whose 34 1997 Mixed Primary 
Combined 
vaccination 
cards and 
self 
reporting
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caretaker had not 
refused the 
vaccination, was 
considered a 
missed 
opportunity"
4 MOV004
Dawria 
(2017) Sudan
Northern 
Africa
"When a child 
who is eligible for 
immunization 
and who has no 
contraindications 
to immunization 
visit a health 
service and 
doesn't receive 
the vaccine" 1 2016 Urban Tertiary
Combined 
vaccination 
cards and 
self 
reporting
5 MOV005
Dyer 
(1993) South Africa
Southern 
Africa
"When a child 
came to a health 
facility and, in the 
absence of any 
contraindication, 
did not receive 
any or all the 
vaccine doses for 
which he or she 
was eligible" 24 1991 Mixed Mixed
Combined 
vaccination 
cards and 
self 
reporting
6 MOV006
Hipgrave 
(1992) Malawi Eastern Africa
"Children less 
than 23 months 
havng an 
incomplete 
immunisation 
schedule, after 
seen by a health 
worker at a 12 Not clear Rural Mixed
Combined 
vaccination 
cards and 
self 
reporting
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facility where 
vaccination is 
available , and 
yet leave without 
being 
immunised"
7 MOV007
Loevinsohn 
(1989) Sudan
Northern 
Africa
"Children coming 
to urban health 
facilities need 
vaccinations but 
are not receiving 
them" 11 Not clear Urban Mixed
Combined 
vaccination 
cards and 
self 
reporting
8 MOV008
Loevinsohn 
(1992) Sudan
Northern 
Africa
"Children coming 
to urban health 
facilities need 
vaccinations but 
are not receiving 
them" 12 Not clear Urban Mixed
Combined 
vaccination 
cards and 
self 
reporting
9 MOV009
McCormick 
(1996) Zimbabwe Eastern Africa
"When a woman 
or child who is 
eligible for 
vaccination visits 
a health facility 
but fails to 
receive that 
vaccination" 4 1995 Urban Mixed
Self 
reported
10 MOV010
Tagbo 
(2005) Nigeria Western Africa
"If a child visits a 
health facility and 
did not receive 
the vaccination 
for which he or 
she was eligible" 1 Not clear Urban Tertiary
Combined 
vaccination 
cards and 
self 
reporting
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11 MOV011
Ubajaka 
(2012) Nigeria Western Africa
"A situation 
whereby a child 
visited a health 
facility and did 
not receive 
vaccine(s) for 
which he or she 
was eligible" 1 2010 Urban Tertiary
Combined 
vaccination 
cards and 
self 
reporting
12 MOV012
WHO 
(1989) Egypt
Northern 
Africa
"Failure to 
immunize a child 
whose 
immunization 
status is not up-
to-date and who 
has no 
contraindications 
is considered a 
missed 
opportunity" 1 1988 Rural Secondary
Combined 
vaccination 
cards and 
self 
reporting
13 MOV013
WHO 
(1990) Ethiopia Eastern Africa
"eligible children 
in need of 
immunization 
who left the 
health facility 
without receiving 
the needed 
immunization" 9 1988 Mixed Mixed
Combined 
vaccination 
cards and 
self 
reporting
14 MOV014
WHO 
(1989) Zimbabwe Eastern Africa
"Due or overdue 
for immunization 
without 
contraindication 
and not 
immunized at 
clinic" 2 1987 Mixed Mixed
Not 
indicated
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15 MOV015
Malual 
(2017)
South 
Sudan Eastern Africa
Definition not 
stated 1 2012 Urban Tertiary
Combined 
vaccination 
cards and 
self 
reporting
16 MOV016
Talani 
(2000) Congo Middle Africa
"Failure to 
vaccinate a child, 
in consultation at 
a health facility, 
who does not 
have any contra-
indication to 
vaccination and 
who returns 
home without 
having received 
all the doses for 
which he is 
eligible" 10 1998 Not Indicated Not clear
Vaccination 
card
17 MOV017
Josse 
(1989) Benin Western Africa
Definition not 
stated 7 1989 Urban Not clear
Vaccination 
card
18 MOV018
Fermon 
(1995)
Republic of 
the Niger Western Africa
"The target 
population 
(incompletely 
vaccinated 
women and 
children) visits a 
health facility 
offering 
vaccination, and 
does not receive 
not the required 
vaccine(s) (in the 5 1992 Urban Mixed Not stated
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absence of any 
contraindication)"
19 MOV019
Himat 
(2003) Sudan
Northern 
Africa
"An opportunity 
for immunization 
is missed when a 
person who is 
eligible for 
immunization 
and who has no 
contraindication 
to immunization 
visits a health 
service and does 
not receive all 
the needed 
vacancies" 11 2003 Mixed Mixed
Combined 
vaccination 
cards and 
self 
reporting
20 MOV020
Onyiriuka 
(2005) Nigeria Western Africa
“Missed 
opportunity is 
when a child who 
needed an 
immunization 
had contact with 
the health 
service but was 
not given the 
vaccination" 1 2003 Urban Secondary
Combined 
vaccination 
cards and 
self 
reporting
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Table 3: Unadjusted Odds ratios of study characteristics from published MOV assessments in Africa
Study characteristics Odds Ratio 95%CI p-Value
Year of publication 0.99 0.93 - 1.05 0.69
Geographical region 1.32 0.91 - 1.92 0.14
WHO region 3.12  1.10 – 8.83 0.03
Sampling strategy 1.03 0.48 - 2.14 0.93
Number of health facilities 1.04 0.98 - 1.10 0.22
Characteristics of location 1.32 0.67 - 2.59 0.40
Means of assessing vaccination 
status 1.67 0.86 – 3.22 0.12
Sample size 1.00 0.99 - 1.00 0.71
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Box 2: Risk of bias analysis of studies included the systematic review
 Selection Performance bias Others
Study ID Author(Year)
sample 
population participation rate 
outcome 
assessment 
Analytical 
methods to 
control for bias 
Other form of 
bias 
MOV001 Borus (2004) High risk Low risk Low risk Low risk Low risk
MOV002 Brugha (1995) Unclear risk Low risk Low risk Low risk Low risk
MOV003 Daly (2003) High risk Low risk Low risk Low risk Low risk
MOV004 Dawria (2017) High risk Low risk Low risk Low risk Low risk
MOV005 Dyer (1993) Low risk Low risk Low risk Low risk Low risk
MOV006 Hipgrave (1992) Unclear risk Low risk Low risk Low risk Low risk
MOV007
Loevinsohn 
(1989) Low risk Low risk Low risk Low risk Low risk
MOV008
Loevinsohn 
(1992) Low risk Low risk Low risk Low risk Low risk
MOV009
McCormick 
(1996) High risk Low risk High risk Low risk Low risk
MOV010 Tagbo (2005) High risk Low risk Low risk Low risk Low risk
MOV011 Ubajaka (2012) Low risk Low risk Low risk Low risk Low risk
MOV012 WHO (1989) Unclear risk Low risk Low risk Low risk Low risk
MOV013 WHO (1990) Unclear risk Low risk Low risk Low risk Low risk
MOV014 WHO (1989) Unclear risk Low risk Low risk Low risk Low risk
MOV015 Malual (2017) High risk Low risk Low risk Low risk Low risk
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MOV016 Talani (2000) Unclear risk Unclear risk Low risk Low risk Low risk
MOV017 Josse (1989) Unclear risk Unclear risk Unclear risk Low risk Low risk
MOV018 Fermon (1995) Unclear risk Unclear risk Low risk Low risk Low risk
MOV019 Himat (2003) High risk Low risk Low risk Low risk Low risk
MOV020
Onyiriuka 
(2005) High risk Low risk Low risk Low risk Low risk
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Figure 3: Forest plot of pooled prevalence of missed opportunities for vaccination among children aged 0 – 23 months in Africa from 
random-effects meta-analysis 
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Figure 4: Contour-enhanced funnel plot of individual studies
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Figure 5:    Causal loop diagram of factors associated with missed opportunities for vaccination
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Box 3: Use of EPICOT+ framework to recommend future primary studies on MOV 
assessment in Africa 
Element Recommendation(s)
Core elements
Evidence (State of evidence) Only systematic review included 20 studies from 14 
African countries were found. 
Population (Population of 
interest) 
MOV assessments using WHO’s updated methodology 
should be used across multiple contexts in Africa as 
follows:  
a. Children aged 0 – 23 months (with analysis 
disaggregated by age group: 0-11 and 12-23 
months)
b. Children attending specialized clinics for HIV, 
sickle cell disease etc. 
c. Children in conflict affected areas
d. Children living in slum and non-slum urban 
areas 
Interventions Based on our findings we recommend small tests of 
change that focus on some of the leverage points 
identified in our CLD through;
a. Facility-based quality improvement projects for 
addressing MOV
b. Collaborative quality improvement projects with 
multiple facilities to address MOV. 
Comparisons Control health facilities
Outcomes Proportion of MOV defined as the number of eligible 
children aged 0 – 23 months who missed vaccination 
(by vaccines and vaccine doses) divided by total 
number of children aged 0 – 23 months attending 
health facility. 
Time stamp January 2018
Optional element
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Study type For MOV Assessments: Cross sectional studies 
employing multilevel analysis approach to account for 
the independent influence of individual and contextual 
factors that can determine MOV. 
For interventions: Quasi experimental studies
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Figure 2: A lin  graph of published studies on MOV in Africa 
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Figure 4: Contour-enhanced funnel plot of individual studies 
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PUBMED
1 Missed[tiab] AND opportunit*[tiab]
2 Immunization[mh] OR immuni*[tiab] OR vaccin*[tiab] OR revaccin*[tiab] OR 
innoculat*[tiab] OR inoculat*[tiab]
3 Africa[MeSH] OR Africa*[tiab] OR Algeria*[tiab] OR Angola*[tiab] OR 
Benin[tiab] OR Botswana[tiab] OR Motswana[tiab] or Batswana[tiab] OR 
Burkina Faso[tiab] OR Burkinabé[tiab] OR Burundi[tiab] OR Cameroon*[tiab] 
OR Canary Islands[tiab] OR Cape Verd*[tiab] OR Central African Republic[tiab] 
OR Chad[tiab] OR Comoros[tiab] OR Comorian*[tiab] OR Congo*[tiab] OR 
Democratic Republic of Congo[tiab] OR Djibouti[tiab] OR Egypt*[tiab] OR 
Equatorial Guinea[tiab] OR Eritrea[tiab] OR Ethiopia*[tiab] OR Gabon*[tiab] 
OR Gambia[tiab] OR Ghana[tiab] OR Guinea[tiab] OR Guinea Bissau*[tiab] OR 
Ivory Coast[tiab] OR Cote d’Ivoire[tiab] OR Ivorian[tiab] OR Jamahiriya[tiab] 
OR Kenya[tiab] OR Lesotho[tiab] OR Mosotho[tiab] or Basotho[tiab] OR 
Liberia[tiab] OR Libya*[tiab] OR Libia[tiab] OR Madagascar[tiab] OR 
Malawi[tiab] OR Mali[tiab] OR Mauritania*[tiab] OR Mauritius[tiab] OR 
Morocc*[tiab] OR Mozambique[tiab] OR Mocambique[tiab] OR 
Mozambican[tiab] OR Namibia[tiab] OR Niger*[tiab] OR Nigeria*[tiab] OR 
Principe[tiab] OR Reunion[tiab] OR Rwanda*[tiab] OR Sao Tome[tiab] OR 
Senegal*[tiab] OR Seychell*[tiab] OR Sierra Leone*[tiab] OR Somali*[tiab] OR 
South Africa*[tiab] OR St Helena[tiab] OR Sudan*[tiab] OR Swazi[tiab] OR 
Swaziland[tiab] OR Tanzania*[tiab] OR Togo[tiab] OR Tunisia*[tiab] OR 
Uganda*[tiab] OR Western Sahara[tiab] OR Zaire[tiab] OR Zambia*[tiab] OR 
Zimbabwe*[tiab]) NOT (guinea pig[tiab] OR guinea pigs[tiab] OR aspergillus 
niger[tiab]
SCOPUS
( TITLE-ABS-KEY ( missed )  AND  TITLE-ABS-KEY ( opportunities )  AND  TITLE-ABS-
KEY ( vaccination )  AND  ALL ( africa ) ) 
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Table A: Factors that cause MOV from individual studies conducted in Africa
S/No Study title
First 
Author
Year of 
Publication Factors
1
Missed opportunities and 
inappropriately given vaccines 
reduce immunisation coverage 
in facilities that serve slum areas 
of Nairobi Borus 2004
Vaccine was out of stock, vaccine schedule not to be 
given on day of visit to the facility, child was sick or 
underweight, child not yet of age, BCG syringe out of 
stock
2
Immunization determinants in 
the Eastern region of Ghana Brugha 1995
Logistical problems at the local hospital, shortage of 
community health nurses to administer vaccines, 
assumption of false contraindications by hospital 
workers, delay in health facility, child illness, female 
literacy, improved economic status, lower parity
3
Missed opportunities for 
vaccination in health facilities in 
Swaziland Daly 2003
Vaccine out of stock, health workers did not check 
cards, patient seen on a day or time when vaccine 
services are not provided, integration of services 
children requiring first dose of all antigens, lack of 
health card, children using facilities providing 
integrated services were more likely to miss 
immunization
4
Missed opportunities of 
immunisation among children 
below 24 months visited Elmak 
Nimir Teaching Hospital, Sudan 
2016 Dawria 2017
No vaccine available, child was ill, tradition and 
customs, afraid from side effect, the vaccination center 
is too far, no enough time
5
Missed opportunities for 
vaccination in Natal health 
facilities Dyer 1993
Non availability of vaccines, routine screening of 
vaccination status, RTH card not requested by the 
health worker,  immunisation given on a different day, 
detailed immunization history not sought, vaccines not 
available, immunization day, pressure of work, 
refrigerator with vaccines in another building, lack of 
emphasis on preventive measures by health workers, 
reluctance to open vaccines for only a few children
6
Missed opportunities for 
immunisation at Kasungu Hipgrave 1992 Health workers related factors
7
Missed opportunities for 
immunization during visits for 
curative care: practical reasons 
for their occurrence Loevinsohn 1989
Not bringing vaccination cards, health workers 
knowledge (lack of training on EPI),attitude and 
practices,  mothers' fear of vaccinating sick children, 
physical arrangement of health facilities
8
Missed opportunities for 
immunzation during visits for 
curative care: a randomized 
cross-over trial in Sudan Loevinsohn 1992
Infants' illness, mother of older children, prior 
immunization history, maternal literacy, age of the 
child, limited access to health facilities 
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9
Missed opportunities for 
vaccination in Chitungwiza, 
Zimbabwe 1995: a service 
deficiency which can easily be 
eliminated McCormick 1996
Vaccine not offered on that day, misinformation about 
vacccine schedule by mothers, attending clinic for 
curative services
10
Missed immunization 
opportunities among children in 
Enugu Tagbo 2005 Low parental education, age of child
11
The prevalence of missed 
opportunities for immunization 
among children utilizing 
immunization services in 
Nnamdi Azikiwe University 
Teaching Hospital Nnewi Ubajaka 2012
Vaccine inavailability, vaccine not available, visit on a 
wrong day, vaccine not open because of a few clients, 
information about immunisation schedule
12
Expanded programme on 
immunization: missed 
opportunities for immunization WHO 1989 Awareness on the importance of vaccination
13
Expanded programme on 
immunization (EPI): missed 
opportunities for immunization WHO 1990
Maternal education, inavailability of vaccines, child 
illness, mother being busy
14
Expanded programme on 
immunization: missed 
immunization opportunities and 
acceptability of immunization WHO 1989
Transportation cost, fever or illness following last 
immunization, lack of knowledge about VPD, not 
being treated with courtesy and respect at 
immunization clinic, living greater than 1 hour away 
from facility, health worker not speaking the same 
language as family, having being turned away from an 
immunization clinic for any reason, receiving 
immunization from a local nurse and not from clinic 
hospital or visiting immunization team survey design, 
ZEPI policy of utilizing every opportunity to 
immunizechildren, immunization card carriage
15
Missed opportunities for 
immunization among children 
attending a paediatric outpatient 
clinic at Juba teaching hospital Malual 2017
Poor knowledge of vaccination schedule, limited 
awareness on contraindication for BCG and polio 
vaccines, inadequate knowledge of health workers and 
caregivers
16
Les occasions de vaccination 
manquées à Brazzaville Talani 2000
Affections, Fever, Respiratory tract infections, Skin 
infections, Prematurity, Vaccines not available, Lack 
of information, Negligence, Lack of time, Lack of 
finances       
17
Vaccination default rates among 
children attending static 
immunization clinic in Benin 
City, Nigeria Onyiruika 2005
Child illness, mother illness, mother forgot, perceived 
contraindication by health workers (cough, cattarh, 
diaheoa) 
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18
Missed opportunities for 
immunization of children under 
two years of Age (0-23 months) 
Dongola province- Northern 
state Himat 2003
Child is ill, child not asked about immunization, 
caretaker does not know the eligibility of the child, 
fear of pain of injection, causes paralysis, causes 
infertility, delay child growth
Table B: Grouping of factors that are responsible for MOV
health service delivery
caregiver utilization of 
immunization services
health workers knowledge 
attitude and practice
Vaccine stock-out Illness in index child
False contraindication to 
vaccinate
Syringe stock-out Underweight child
Routine screening of 
immunization cards
Vaccination clinic scheduling Caregiver literacy level Seeking immunization history
Shortage of health workers 
(vaccinators) Socioeconomic status Workload
Delays in clinics Low parity
Reluctance to open new 
vaccine vial
Integration of services Child health card
Lack of emphasis on 
preventive services
Organization of facilities First dose of antigen Training on EPI
 
Traditional beliefs and 
customs  
 Fear of side effects  
 Distance to health facility  
 Time  
 Cost implication  
 
Fear of vaccinating an ill child 
(Fever)  
 Age of child  
 Previous immunization  
 Knowledge  
 Curative services  
 
Fever or illness following last 
immunization  
 Attitude of health workers  
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